SCHOTT Pharma AG & Co. KGaA (VIE:1SXP)

Austria · Delayed Price · Currency is EUR

14.42

+0.08 (0.56%)

At close: Jan 30, 2026

Revenue by Product

Financials in millions EUR. Fiscal year is October - September.

Millions EUR. Fiscal year is Oct - Sep.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Drug Containment Solutions	518.36M
Drug Containment Solutions Growth	-6.60%
Drug Delivery Systems	438.74M
Drug Delivery Systems Growth	27.67%

Revenue by Geography

Financials in millions EUR. Fiscal year is October - September.

Millions EUR. Fiscal year is Oct - Sep.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
EMEA	540.30M
EMEA Growth	20.24%
North America	144.74M
North America Growth	-10.91%
Asia and South Pacific	112.74M
Asia and South Pacific Growth	10.75%
South America	79.90M
South America Growth	-2.56%
Germany	79.42M
Germany Growth	-22.88%